CollPlant Biotechnologies Ltd. (CLGN) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

CollPlant Biotechnologies... (CLGN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.84

-0.06 (-1.54%)

At close: Jan 14, 2025, 2:30 PM

3.84

0.00%

After-hours Jan 14, 2025, 02:31 PM EST

undefined% (undefined)

Bid	3.21
Market Cap	44.03M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.53
PE Ratio (ttm)	-2.51
Forward PE	n/a
Analyst	Buy

Ask	5
Volume	1,354
Avg. Volume (20D)	14,834
Open	3.92
Previous Close	3.90
Day's Range	3.84 - 3.92
52-Week Range	3.24 - 6.75
Beta	undefined

About CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jan 31, 2018

Employees 75

Stock Exchange NASDAQ

Ticker Symbol CLGN

Website https://www.collplant.com

Analyst Forecast

According to 3 analyst ratings, the average rating for CLGN stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 264.21% from the latest price.

Buy 66.67%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

CollPlant Biotechnologies Ltd. is scheduled to release its earnings on Apr 3, 2025, before market opens.
Analysts project revenue of $760.00K, reflecting a 154.18% YoY growth and earnings per share of -0.42, making a 20.00% increase YoY.

Why Price Moved

1 month ago · Source

-0.23%

CollPlant Biotechnologies shares are trading lower... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd (NASDAQ:CLGN ) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy C...